Skip to main content
HUMASIS CO., LTD. logo

HUMASIS CO., LTD. — Investor Relations & Filings

Ticker · 205470 ISIN · KR7205470008 KO Manufacturing
Open in API
Filings indexed 333 across all filing types
Latest filing 2023-03-08 Audit Report / Informat…
Country KR South Korea
Listing KO 205470

About HUMASIS CO., LTD.

https://www.humasis.com/en/

Humasis Co., Ltd. is a company specializing in the research, development, and manufacturing of in-vitro diagnostic (IVD) devices, with a primary focus on Point-of-Care Testing (POCT). The company develops and produces a range of rapid diagnostic solutions, including immunodiagnostic kits for the early screening of various diseases, compact instruments for quantitative analysis, and personal health care products. A key operational strength is the in-house development and production of critical bio-materials, such as diagnostic immune antigens, which ensures the consistent performance and accuracy of its products. Humasis aims to provide technologies for precise and rapid disease analysis to support clinical decision-making and promote individual health management.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Humasis. It contains the auditor's opinion (적정/Unqualified), financial statements (consolidated and separate), and key financial metrics for the fiscal year. While it provides financial data, it is a regulatory filing announcing the completion and submission of the audit report to the exchange, rather than the full 10-K annual report document itself. Therefore, it is classified as an Audit Report/Information filing. FY 2022
2023-03-08 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by shareholders to solicit proxies from other shareholders for an upcoming general meeting. It contains the solicitor's information, the purpose of the solicitation (opposing management's agenda), and details regarding the upcoming Annual General Meeting. While it contains financial data, this is provided as part of the proxy solicitation materials to support the solicitor's arguments, not as an official Annual Report (10-K) or Interim Report (IR). Therefore, it is classified as a Proxy Solicitation & Information Statement.
2023-03-02 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) for the company Humasis, dated 2023-02-28. It details the voting outcomes for various agenda items, including the appointment of directors and auditors, and the approval of remuneration limits. This falls directly under the category of Declaration of Voting Results & Voting Rights Announcements.
2023-02-28 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the previous and new CEOs, the reason for the change (business expansion and management efficiency), and the date of the board resolution. This falls directly under the category of board/management changes.
2023-02-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing titled '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the Appointment, Dismissal, or Resignation of Outside Directors). It details changes to the board of directors, specifically the appointment of an outside director following an extraordinary general meeting. This falls under the category of board and management changes.
2023-02-28 Korean
[기재정정]주주총회소집결의(임시주주총회)
AGM Information Classification · 98% confidence The document is a formal regulatory filing from Humasis regarding the 'Resolution to Convene a General Meeting of Shareholders' (specifically an Extraordinary General Meeting). It details amendments to the agenda, including the withdrawal of certain director and auditor candidates, and provides information on the meeting date, location, and proposed business objectives. This type of document is a standard proxy-related disclosure used to inform shareholders of meeting details and agenda changes, which falls under the Proxy Solicitation & Information Statement category.
2023-02-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.